Patients with RA present constitutively high serum levels of pro-inflammatory cytokines, including TNF-α, IL-1β, IL-6 or IL-17, which are known to be NF-κB target genes, suggesting activation of this signaling pathway in the course of disease. This evidence concerns the gene NFKB1 and rheumatoid arthritis.